1 / 4

Fondaparinux Market Size & Forecast Report by 2024

Global Fondaparinux Market is expected to reach USD 686.3 billion by 2024. Fondaparinux is also termed as Fondaparinux sodium or Natural heparin pentasaccharide is an anticoagulant medication chemically related to low molecular weight heparins. Its trade name is Arixtra. Its molecular formula is C31H53N3O49S8 and molecular weight is 1508.217 g/mol. Factor Xa inhibits its activity and interrupts the blood coagulation cascade by stopping thrombus development and thrombin formation. It is a synthetic glucopyranoside with antithrombotic activity. The Fondaparinux Market is estimated to grow at a s

6853
Download Presentation

Fondaparinux Market Size & Forecast Report by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Fondaparinux Market Size & Forecast Report by 2024 “Growing number of hip and knee surgeries, mounting cooperation between major players for securing the intellectual property rights (IPRs), growing aging population and diseases like orthopedic conditions and heart infections are documented as major factors of Fondaparinux Market that are estimated to enhance the growth in the years to come.” Global Fondaparinux Market is expected to reach USD 686.3 billion by 2024. Fondaparinux is also termed as Fondaparinux sodium or Natural heparin pentasaccharide is an anticoagulant medication chemically related to low molecular weight heparins. Its trade name is Arixtra. Its molecular formula is C31H53N3O49S8 and molecular weight is 1508.217 g/mol. Factor Xa inhibits its activity and interrupts the blood coagulation cascade by stopping thrombus development and thrombin formation. It is a synthetic glucopyranoside with antithrombotic activity. The Fondaparinux Market is estimated to grow at a significant CAGR of 7.8% over the forecast period as the scope and its applications are rising enormously across the globe. Growing number of hip and knee surgeries, mounting cooperation between major players for securing the intellectual property rights (IPRs), growing aging population and diseases like orthopedic conditions and heart infections are documented as major factors of Fondaparinux Market that are estimated to enhance the growth in the years to come. However, severe side effects of drugs may restrain overall market in the coming years. Fondaparinux Market is segmented based on product type, application, end user, and region. Generics drug and branded drug are the product types that could be explored in Fondaparinux during the forecast period. The market may be categorized based on applications like abdominal surgery, orthopedics (knee or hip replacement), cardiovascular, and others that could be explored in the forecast period. Home care settings, clinics, ambulatory surgical centers, hospitals, diagnostic centers, and other end users could be explored in Fondaparinux during the forecast period. Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry- reports/fondaparinux-market/request-sample Globally, North America accounted for the substantial market share of Fondaparinux and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be presence of key manufacturers in the region, growing awareness among populace regarding brand and upcoming drugs, and technological enhancements as growing aging population. The United States is a major consumer of Fondaparinux in this region.

  2. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing awareness among patients and healthcare sectors and developing industries in this region. The developing countries like India and China are the major consumers of Fondaparinux in this region. The key players of Fondaparinux industry are Kaifeng Pharmaceutical, Pfizer, Inc., WisMed Pharmaceuticals, Bayer Healthcare AG, Eisai Inc., GlaxoSmithKline Plc., Bristol-Myers Squibb Company, BoehringerIngelheim, Aspen Holdings, Sanofi S.A., Abbott India Limited, and Apotex. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/fondaparinux-market Market Segment: Fondaparinux market, product outlook by revenue (USD Million, 2011 - 2024) • Branded • Generics Fondaparinux market, product outlook by volume (thousand units, 2011 - 2024) • Branded • Generics Fondaparinux market, regional outlook by revenue (USD Million, 2011 - 2024) • North America • Europe • Asia Pacific • China • RoW Fondaparinux market, regional outlook by volume (thousand units, 2011 - 2024) • North America • Europe • Asia Pacific • China • RoW See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

  3. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184

More Related